ICH Q10 – Pharmaceutical Quality Systems - ‘An Opportunity for Us All'
If you have not yet reviewed the content of the ICH Q10 guideline and considered its impact on your company's quality system operations, then it makes good busi...
Executive Abstract
This white paper will attempt to convince you, the reader, that this common argument is not valid and that something new is necessary (i.e., ICH Q10) to improve the performance of the pharmaceutical industry and to facilitate more science and risk-based regulatory approaches.
Unlock Report Access
Complete this brief form for instant PDF access.
Related Executive Research
White Paper
The Challenges of Building an Effective Structure for Sponsor-CRO Partnership
The growth of Contract Research Organizations (CROs) as an industry is inevitable. When the global economy is thriving, life science companies are inclined to d...
Guide
Selling CBD: Answering Common Customer Questions
Developed by CANVIVA, this guide will help business owners and their employees answer common customer questions about CBD. CBD (cannabidiol) is everywhere in t...